Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $18.21 Analyst target: $35.33 Upside: 94.01%
Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapies for oncology and infectious diseases. The company is headquartered in Exton, Pennsylvania.
See the full interactive analysis & chart →Informational only — not investment advice.